Intestinal Failure-Associated Liver Disease

Area of Science:

• Hepatology
• Gastroenterology
• Nutrition Science

Background:

• Intestinal failure-associated liver disease (IFALD) is a complication in patients requiring long-term home parenteral nutrition for chronic intestinal failure.
• IFALD presents as liver steatosis or cholestasis, significantly impacting patient health outcomes.

Purpose of the Study:

• To elucidate the multifactorial pathogenesis of IFALD.
• To identify key risk factors and mechanisms contributing to IFALD development.
• To outline strategies for IFALD prevention and treatment.

Main Methods:

• Review of existing literature on IFALD pathogenesis.
• Analysis of factors related to gastrointestinal disease, parenteral nutrition, and systemic conditions.
• Identification of mechanisms such as altered bile acid circulation, gut microbiome changes, and intestinal permeability.

Main Results:

• IFALD pathogenesis is multifactorial, involving gastrointestinal, parenteral nutrition, and systemic factors.
• Altered bile acid enterohepatic circulation, gut microbiome dysbiosis, and increased intestinal permeability are primary mechanisms.
• Total oral fasting, parenteral nutrition overfeeding, and soybean-based lipid emulsions are identified as contributing factors.

Conclusions:

• IFALD is a complex liver condition linked to chronic intestinal failure and parenteral nutrition.
• Understanding the multifactorial nature and key mechanisms is crucial for effective management.
• Prevention and treatment strategies should focus on mitigating identified risk factors.